Cellect Biotechnology Ltd...

NASDAQ: APOP · Real-Time Price · USD
13.17
0.05 (0.38%)
At close: Oct 29, 2021, 6:00 AM

Cellect Biotechnology Income Statement

Financials in ILS. Fiscal year is undefined.
Fiscal Year FY 2024
Period Ending Dec 31, 2024
Revenue
n/a
Cost of Revenue
n/a
Gross Profit
n/a
Operating Income
n/a
Interest Income
n/a
Pretax Income
-8.96B
Net Income
-8.96B
Selling & General & Admin
5.93B
Research & Development
3.6B
Other Expenses
n/a
Operating Expenses
9.53B
Interest Expense
n/a
Selling & Marketing Expenses
n/a
Cost & Expenses
n/a
Income Tax Expense
n/a
Shares Outstanding (Basic)
133.97K
Shares Outstanding (Diluted)
133.97K
EPS (Basic)
-66.9K
EPS (Diluted)
-66.9K
EBITDA
n/a
EBIT
n/a
Depreciation & Amortization
n/a